Neumora Therapeutics

NMRANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$92.351 M

$0.49 -13.16%

Close of 6 Nov 2026

As of 6 Nov 2026, Neumora Therapeutics (NMRA) has a market capitalization of $92.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$236.9M

#925 by earnings

Shares outstanding

187,895,912

Latest filing cover page

P/E ratio

0.4

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#113Black Diamond TherapeuticsBDTX$95.7M
#114LENZ TherapeuticsLENZ$95.4M
#115Neumora TherapeuticsNMRA$92.4M
#116Atara BiotherapeuticsATRA$80.7M
#117OKYO PharmaOKYO$73.5M

What if Neumora Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$150,279.34

Per share 305,757× higher

Bitcoin $1.53T

$8,131.35

Per share 16,544× higher

Apple $5.02T

$26,694.47

Per share 54,312× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Neumora Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.